Impact of Health Care Professional Supervision on Quality of Life in Cancer Patients
The Impact of Supervision by a Health Care Professional on Quality of Life (QoL) Questionnaire Scoring and Completion:, Randomized, Cross-over Study in Cancer Patients Receiving Systemic Antineoplastic Therapy
This study tests if having a healthcare professional help cancer patients fill out quality of life questionnaires makes their answers more accurate and reliable.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | St. Claraspital AG Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 1 site (Basel, Canton of Basel-City) |
| Trial ID | NCT06490393 on ClinicalTrials.gov |
What this trial studies
This study investigates how supervision by a healthcare professional affects the completion and scoring of Quality of Life (QoL) questionnaires among cancer patients undergoing systemic antineoplastic therapy. It employs a multi-center, randomized, cross-over design to assess sensitive domains of QoL. Participants will complete questionnaires in German, and the study aims to determine if supervision improves the accuracy and reliability of their responses.
Who should consider this trial
Good fit: Ideal candidates are adult cancer patients aged 18 and older who are currently receiving systemic oncologic treatment and can complete questionnaires in German.
Not a fit: Patients who are not currently undergoing systemic oncologic treatment or cannot complete the questionnaires in German may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the accuracy of QoL assessments, leading to better patient care and tailored treatment plans.
How similar studies have performed: While the specific approach of this study may be novel, similar studies have shown that supervision can improve data quality in clinical assessments.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient is ≥18 years of age and legally competent * Signed informed consent available * Systemic oncologic treatment (e.g. chemotherapy, immunotherapy, endocrine therapy) * Current systemic therapy started at least 4 weeks before randomization and is scheduled to continue for at least another 4 weeks after randomization in the same dose and interval * Patient is ready and able to complete quality of life questionnaires in German (on paper Exclusion Criteria: * One or more of the inclusion criteria not met.
Where this trial is running
Basel, Canton of Basel-City
- St Clara Research Ltd — Basel, Canton of Basel-City, Switzerland (Recruiting)
Study contacts
- Principal investigator: Diana de Jong-Bakker — St. Claraspital Klinische Forschung
- Study coordinator: Diana de Jong-Bakker
- Email: diana.bakkerdejong@claraspital.ch
- Phone: +41616853604
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.